Korea Arlico Pharm Co.,Ltd.

KOSDAQ:A260660 Rapporto sulle azioni

Cap. di mercato: ₩69.0b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Korea Arlico PharmLtd Gestione

Gestione criteri di controllo 0/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Hang-Gu Lee

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOno data
Proprietà del CEO39.1%
Durata media del managementNessun dato
Durata media del Consiglio di amministrazioneNessun dato

Aggiornamenti recenti sulla gestione

Recent updates

There's Reason For Concern Over Korea Arlico Pharm Co.,Ltd.'s (KOSDAQ:260660) Price

Aug 04
There's Reason For Concern Over Korea Arlico Pharm Co.,Ltd.'s (KOSDAQ:260660) Price

Is Korea Arlico PharmLtd (KOSDAQ:260660) Using Too Much Debt?

Mar 24
Is Korea Arlico PharmLtd (KOSDAQ:260660) Using Too Much Debt?

Should You Be Adding Korea Arlico PharmLtd (KOSDAQ:260660) To Your Watchlist Today?

Mar 02
Should You Be Adding Korea Arlico PharmLtd (KOSDAQ:260660) To Your Watchlist Today?

Korea Arlico PharmLtd's (KOSDAQ:260660) Shareholders Are Down 50% On Their Shares

Feb 12
Korea Arlico PharmLtd's (KOSDAQ:260660) Shareholders Are Down 50% On Their Shares

What Is The Ownership Structure Like For Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)?

Jan 25
What Is The Ownership Structure Like For Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)?

Should You Use Korea Arlico PharmLtd's (KOSDAQ:260660) Statutory Earnings To Analyse It?

Jan 04
Should You Use Korea Arlico PharmLtd's (KOSDAQ:260660) Statutory Earnings To Analyse It?

Is Korea Arlico PharmLtd (KOSDAQ:260660) A Risky Investment?

Dec 16
Is Korea Arlico PharmLtd (KOSDAQ:260660) A Risky Investment?

Are Strong Financial Prospects The Force That Is Driving The Momentum In Korea Arlico Pharm Co.,Ltd.'s KOSDAQ:260660) Stock?

Nov 25
Are Strong Financial Prospects The Force That Is Driving The Momentum In Korea Arlico Pharm Co.,Ltd.'s KOSDAQ:260660) Stock?

AMMINISTRATORE DELEGATO

Hang-Gu Lee (63 yo)

no data

Mandato

Mr. Hang-Gu Lee is Chief Executive Officer of Korea Arlico Pharm Co.,Ltd.